HEBEI HUARONG PHARMACEUTICAL CO LTD

Overview

HEBEI HUARONG PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 25 active FDA Type II Drug Master Files, covering ACARBOSE; ACETAMINOPHEN; ACETAMINOPHEN DC 90%; BLEOMYCIN SULFATE; BORTEZOMIB; COBAMAMIDE.

API / Drug Master Files

HEBEI HUARONG PHARMACEUTICAL CO LTD holds 25 active (27 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• FIDAXOMICINActive2026-01-20
• BLEOMYCIN SULFATEActive2025-11-07
• SEVOFLURANEActive2025-06-22
• DESFLURANEActive2025-06-22
• ISOFLURANEActive2025-06-22
• VINBLASTINE SULFATE NON-STERILE, BULK DRUG SUBSTANCEActive2025-01-07
• VINCRISTINE SULFATEActive2024-09-15
• BORTEZOMIBActive2024-06-15
• VINBLASTINE SULFATE PHARMACEUTICAL INTERMEDATEActive2024-03-18
• MITOMYCINActive2023-10-10
• MELPHALANActive2023-10-05
• HYDROXOCOBALAMIN ACETATEActive2023-07-24
• IVERMECTINActive2023-06-27
• ACETAMINOPHENActive2022-11-28
• MECOBALAMINActive2021-08-30

Showing 15 of 27 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to HEBEI HUARONG PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.